United States · FDA National Drug Code directory
REDEMPLO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84141-025_4b987e0d-345d-4ba3-b5d6-d70c1bfe0fd7
- Product NDC
- 84141-025
- Form
- INJECTION, SOLUTION
- Composition / generic term
- plozasiran
- Labeler
- Arrowhead Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251119
- Source listing expiry
- 20271231
Source-listed ingredients
- PLOZASIRAN — 25 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS · 84141-025-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →